Skip to main content
logo
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.530
+0.060 (1.73%)
Aug 10, 2026, 9:55 AM EDT - Market open

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Cap
136213--
Market Cap Growth
464.44%136.47%-82.20%---
Enterprise Value
6.02-1.8-3.7520.3300
Last Close Price
3.532.4626.253740.63--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--0.80---
PB Ratio
0.470.330.35-1.22--
P/TBV Ratio
0.120.080.12---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/EBITDA Ratio
-0.291.02---
EV/EBIT Ratio
-0.291.02---
EV/FCF Ratio
-0.221.00---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-00-0.7000
Net Debt / Equity Ratio
-0.44-0.44-0.91-0.636.66-1.03
Net Debt / EBITDA Ratio
1.201.201.68-2.520.41-
Net Debt / FCF Ratio
0.910.911.64-2.350.841.26
Quick Ratio
12.5312.5310.550.060.8313.62
Current Ratio
14.6214.6211.040.090.8913.90
Return on Equity (ROE)
-40.95%-58.62%-47.61%915.76%-428.02%0.00%
Return on Assets (ROA)
-35.51%-50.13%-86.71%-202.16%-189.14%0.00%
Return on Invested Capital (ROIC)
-65.66%-121.64%-87.02%-71.82%--
Return on Capital Employed (ROCE)
-36.81%-52.71%172.36%49.26%-431.82%0.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
--124.80%---
Buyback Yield / Dilution
-1688.07%-1688.07%----
Total Shareholder Return
-1688.07%-1688.07%----
SEC Filings: 10-K · 10-Q